AzTrials
AzTrials

DengueIRDDENGUELANCT05893134

Identification of Risk Determinants of Dengue Transmission Through Landscape Analysis

An observational study of Dengue, run by Instituto Mexicano del Seguro Social at 1 site in Mexico.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This retrospective observational study aims to determine the probability of the risk of dengue transmission through a model based on epidemiological, entomological, socioeconomic, demographic, and landscape variables in the El Vergel neighborhood in the municipality of Tapachula, Chiapas, Mexico. Read more about this study

Who is it for?
Any age
Conditions the study is for
Dengue
What is being tested?
Risk Assessment
How many people
196 participants
Where
1 siteMexico
Study dates
1 Jun 2023to 30 Jan 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: The Health District VII (DSVII) of the State Health Services (SESAs) in Chiapas, Mexico, will be asked for the database of dengue cases in the study area during the time of the implementation of the surveys (November 19 to December 5 of 2019), six months before and six months after the said period. They will be georeferenced through field visits, through the measurement of a geographical point in front of the house.

Who may be able to join

  • The epidemiological information of all suspected cases of dengue with the onset of symptoms in the period from June 2019 to May 2020 that have a record on the platform of the National System for Epidemiological Surveillance will be included.

Who cannot join

  • Records that do not have sufficient information for their georeferencing will be excluded.

Trial locations and contacts

1 site in 1 country.

Mexico1 site
  • Hospital General de Zona No. 1

    Tapachula, Chiapas, 30700

Other trials in Mexico

About this study

Official title: Identification of Risk Determinants of Dengue Transmission Through Landscape Analysis in the Neighborhood "El Vergel", Tapachula, Chiapas

This retrospective observational study aims to determine the probability of the risk of dengue transmission through a model based on epidemiological, entomological, socioeconomic, demographic, and landscape variables in the El Vergel neighborhood in the municipality of Tapachula, Chiapas, Mexico.

The main question it aims to answer is:

  1. Is it possible to identify the risk determinants of dengue transmission by developing a probabilistic model based on the landscape analysis of epidemiological, entomological, sociodemographic, and landscape variables in an endemic urban area of the municipality of Tapachula, Chiapas, Mexico? Participants will be selected from a registry obtained from the Secretary of Health of cases of dengue fever, which will be contrasted with the entomological, socioeconomic, demographic, and landscape variables in the El Vergel neighborhood in Tapachula, Chiapas, Mexico. They will be not contacted or sampled for biologic testing in any shape or form, only the data already collected from the health services will be used.
Read the detailed description

Identification of the risk determinants of dengue transmission through landscape analysis in the "El Vergel" neighborhood, Tapachula, Chiapas, Mexico Dengue is a disease transmitted mainly by the Ae. aegypti present in our region, despite vector surveillance and control activities, the circulation of the virus is constant and new strategies are required that contribute to reducing the incidence of the disease, which can be fatal. On the other hand, drones are tools already used in precision and security agriculture, among others; by means of them, it is possible to obtain high-resolution images of large areas of land. This work will use these images in combination with epidemiological, entomological, socioeconomic, and demographic data to identify the risk factors for dengue transmission in an urban area of the city of Tapachula and will generate a model that will allow defining the risk areas in the area. study.

Objective: To determine the probability of the risk of dengue transmission through a model based on epidemiological, entomological, socioeconomic, demographic, and landscape variables in the El Vergel neighborhood in the municipality of Tapachula, Chiapas.

Material and methods: Information from entomological, housing condition, and sociodemographic surveys of the El Vergel neighborhood, Tapachula, Chiapas, obtained during the period from November to December 2019, will be used. In addition to epidemiological information on the incidence of dengue and the placement of ovitraps in the study area during the sampling period, six months before and six months after. Specialized cartography will be used, made from fine-scale aerial photographs taken at a height of 100m by a multirotor drone with six DJI Matrice 600 model rotors with two types of cameras, a Zenmuse X5 model that captures images in the visible spectrum at 16 MP and a multispectral camera with five spectral bands MicaSense RedEdge -MX with RGB sensor with a spatial resolution of 5 cm per pixel. The images were taken simultaneously with the entomological, socioeconomic, and demographic surveys. Georeferenced orthophoto cartographic maps, digital surface models, digital terrain models, and specialized cartography of vegetation indices will be used: Normalized Difference Vegetation Index (NDVI), Difference Vegetation Index Green Normalized (GNDVI), RedEdge Normalized Difference Vegetation Index (NDVIRe) and Chlorophyll Index (CIGreen), height and diameter of the trees present in the study area, to take various variables related to the landscape (environmental variables). The data analysis will be based on a mathematical model based on the principle of partial least squares, to determine the spatial association between the epidemiological indicators (number and georeferencing of cases), entomological (immature and adult stages of Ae. aegypti), condition index housing, sociodemographic and landscape data.

Period: 6 months Type of study: Cross-sectional, retrospective, observational. Selection criteria: The construction of databases will consider the houses of Colonia El Vergel, Tapachula, Chiapas, where its inhabitants of legal age, accepted through informed consent to participate in the surveys and collection of entomological and sociodemographic data in situ and aerial photographs at a height of 100m away. Homes that do not have residents will be grounds for exclusion, and those in which the participants do not allow the collection of complete information will be eliminated.

Sample size and sampling: A multi-stage stratified sampling will be used to select dwellings. The sample size will be obtained according to the sample formula for proportions, which was calculated in n=196 dwellings.

Results: A probabilistic risk model will be generated based on the variables of different natures used and maps will be built to identify the areas of greatest risk for dengue transmission in the study area.

Conclusion: Generate scientific evidence that allows maximum use of these advances for the benefit of populations. The determination of risk areas using specialized cartography carried out using high-resolution aerial photography using drones, has already been demonstrated and recently published.

Conditions
Dengue
Being tested
Risk Assessment
Keywords
dengue fever, risk determinants, landscape analysis
Medical subject headings
Dengue

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Risk AssessmentOther

    A probabilistic risk model will be generated based on the variables of different natures used and maps will be built to identify the areas of greatest risk for dengue transmission in the study area

Study groups in NCT05893134
Study groupRoleWhat they receive
MainInformation from entomological, housing condition, and sociodemographic surveys of the El Vergel neighborhood, Tapachula, Chiapas, obtained during the period from November to December 2019, will be used
Receives: Other: Risk Assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Risk

    A probabilistic risk model will be generated based on the variables of different natures used and maps will be built to identify the areas of greatest risk for dengue transmission in the study area

    Measured: One year, six months previous to the survey application (November-December 2019) and six months after

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jun 2023
  2. Study start1 Jun 2023
  3. Primary completion31 Jul 2023
  4. Study completion30 Jan 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Retrospective
Enrolment
196 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05893134
Sponsor's protocol ID
F-CNIC-2023-060
Acronym
IRDDENGUELA
Status last verified
Mar 2024
First submitted
26 May 2023
Last updated
5 Mar 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The information of the participating subjects will only be used for the selection of homes with dengue cases, they will not be contacted or any sample will be obtained, or any drug will be used in them. Therefore, the personal information of the subjects will not be shared in order not to compromise their confidentiality.

Publications

  • Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998 Jul;11(3):480-96. doi: 10.1128/CMR.11.3.480.

    PubMed 9665979
  • Bennett JE, Dolin R, Blaser MJ, editores. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Ninth edition. Philadelphia, PA: Elsevier; 2020. 1 p.

  • World Health Organization. (2012). Global strategy for dengue prevention and control 2012-2020. World Health Organization. https://apps.who.int/iris/handle/10665/75303

  • Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI. The global distribution and burden of dengue. Nature. 2013 Apr 25;496(7446):504-7. doi: 10.1038/nature12060. Epub 2013 Apr 7.

    PubMed 23563266
  • Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, Moyes CL, Farlow AW, Scott TW, Hay SI. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis. 2012;6(8):e1760. doi: 10.1371/journal.pntd.0001760. Epub 2012 Aug 7.

    PubMed 22880140
  • Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, Jones CT, Mukhopadhyay S, Chipman PR, Strauss EG, Baker TS, Strauss JH. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell. 2002 Mar 8;108(5):717-25. doi: 10.1016/s0092-8674(02)00660-8.

    PubMed 11893341
  • Guzman MG, Harris E. Dengue. Lancet. 2015 Jan 31;385(9966):453-65. doi: 10.1016/S0140-6736(14)60572-9. Epub 2014 Sep 14.

    PubMed 25230594
  • Pardo Martínez D, Ojeda Martínez B, Alonso Remedios A. Dinámica de la respuesta inmune en la infección por virus del dengue. MediSur. febrero de 2018;16:76-84.

  • Avirutnan P, Matangkasombut P. Unmasking the role of mast cells in dengue. Elife. 2013 Apr 30;2:e00767. doi: 10.7554/eLife.00767.

    PubMed 23638302
  • Orta-Pineda G, Abella-Medrano CA, Suzan G, Serrano-Villagrana A, Ojeda-Flores R. Effects of landscape anthropization on sylvatic mosquito assemblages in a rainforest in Chiapas, Mexico. Acta Trop. 2021 Apr;216:105849. doi: 10.1016/j.actatropica.2021.105849. Epub 2021 Jan 30.

    PubMed 33524383
  • Tun-Lin W, Kay BH, Barnes A. Understanding productivity, a key to Aedes aegypti surveillance. Am J Trop Med Hyg. 1995 Dec;53(6):595-601. doi: 10.4269/ajtmh.1995.53.595.

    PubMed 8561260
  • Scott TW, Morrison AC. Vector dynamics and transmission of dengue virus: implications for dengue surveillance and prevention strategies: vector dynamics and dengue prevention. Curr Top Microbiol Immunol. 2010;338:115-28. doi: 10.1007/978-3-642-02215-9_9.

    PubMed 19802582
  • Reinhold JM, Lazzari CR, Lahondere C. Effects of the Environmental Temperature on Aedes aegypti and Aedes albopictus Mosquitoes: A Review. Insects. 2018 Nov 6;9(4):158. doi: 10.3390/insects9040158.

    PubMed 30404142
  • Carrasco-Escobar G, Moreno M, Fornace K, Herrera-Varela M, Manrique E, Conn JE. The use of drones for mosquito surveillance and control. Parasit Vectors. 2022 Dec 16;15(1):473. doi: 10.1186/s13071-022-05580-5.

    PubMed 36527116
  • Ferraguti M, Martinez-de la Puente J, Roiz D, Ruiz S, Soriguer R, Figuerola J. Effects of landscape anthropization on mosquito community composition and abundance. Sci Rep. 2016 Jul 4;6:29002. doi: 10.1038/srep29002.

    PubMed 27373794

Questions about this trial

What is this clinical trial studying?

An observational study of Dengue, run by Instituto Mexicano del Seguro Social at 1 site in Mexico.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Mexico. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Risk (time frame: One year, six months previous to the survey application (November-December 2019) and six months after). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05893134, which also lists 34 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in